Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 March 1994 | Volume 120 Issue 6 | Pages 463-469
Objective: To determine
Setting: Clinical Center, National Institutes of Health.
Patients: 25 patients with aplastic anemia on presentation, 18 patients after treatment, 39 patients with other hematologic syndromes, and 20 normal controls.
Measurements and Main Results:
Conclusions:
Author and Article Information
From the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
ARTICLE
Gamma-Interferon Gene Expression in the Bone Marrow of Patients with Aplastic Anemia
-interferon gene expression in the bone marrow of patients with aplastic anemia and controls. Most patients with acquired aplastic anemia respond to immunosuppressive therapy, implicating an immune pathophysiologic origin for this disease.
-Interferon signal was detected in the bone marrow of 14 of 18 patients with severe aplasia on presentation, 4 of 7 patients with moderate aplastic anemia, and 1 of 2 patients with the paroxysmal nocturnal hemoglobinuria-aplasia syndrome. The
-interferon gene was not expressed in marrow from 20 normal persons or in patients who had received many transfusions for chronic anemia; with pancytopenia after chemotherapy; or with marrow failure of other types, including myelodysplasia, inherited anemias, or constitutional aplastic anemia. In serial studies,
-interferon RNA disappeared from the marrow of patients as they responded to immunosuppression; the signal was present in 3 of 4 patients who had a relapse but not in previously treated, now recovered patients. Determination of marrow
-interferon gene expression was more specific and sensitive than concurrent determinations in peripheral blood. Quantitative titration of mRNA showed that
-interferon expression was not a simple function of the number of lymphocytes in samples.
-Interferon expression is prevalent in acquired aplastic anemia and may be a specific marker of this disease. Local production of this inhibitory lymphokine in the target organ, the bone marrow, may be important in mediating aplastic anemia. Measurement of this lymphokine's message may be useful in distinguishing acquired aplastic anemia from other forms of bone marrow failure.
![]()
Requests for Reprints: Antonia Nistico, MD, 10/7C103, National Institutes of Health, Bethesda MD 20892.
Acknowledgments: The authors thank Donna Vining, RN, and Janice Kimball, RN, for help in assembling the clinical data, Stacie Anderson for doing immunophenotyping and immunoassays, and Dr. Stacie Goodman for providing some marrow samples.
This article has been cited by other articles:
![]() |
W. Zeng, A. Miyazato, G. Chen, S. Kajigaya, N. S. Young, and J. P. Maciejewski Interferon-{gamma}-induced gene expression in CD34 cells: identification of pathologic cytokine-specific signature profiles Blood, January 1, 2006; 107(1): 167 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Katsoulidis, Y. Li, P. Yoon, A. Sassano, J. Altman, P. Kannan-Thulasiraman, L. Balasubramanian, S. Parmar, J. Varga, M. S. Tallman, et al. Role of the p38 Mitogen-Activated Protein Kinase Pathway in Cytokine-Mediated Hematopoietic Suppression in Myelodysplastic Syndromes Cancer Res., October 1, 2005; 65(19): 9029 - 9037. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yang, I. Dybedal, D. Bryder, L. Nilsson, E. Sitnicka, Y. Sasaki, and S. E. W. Jacobsen IFN-{gamma} Negatively Modulates Self-Renewal of Repopulating Human Hemopoietic Stem Cells J. Immunol., January 15, 2005; 174(2): 752 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dufour, A. Corcione, J. Svahn, R. Haupt, V. Poggi, A. N. Beka'ssy, R. Scime, A. Pistorio, and V. Pistoia TNF-{alpha} and IFN-{gamma} are overexpressed in the bone marrow of Fanconi anemia patients and TNF-{alpha} suppresses erythropoiesis in vitro Blood, September 15, 2003; 102(6): 2053 - 2059. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Verma, D. K. Deb, A. Sassano, S. Kambhampati, A. Wickrema, S. Uddin, M. Mohindru, K. Van Besien, and L. C. Platanias Cutting Edge: Activation of the p38 Mitogen-Activated Protein Kinase Signaling Pathway Mediates Cytokine-Induced Hemopoietic Suppression in Aplastic Anemia J. Immunol., June 15, 2002; 168(12): 5984 - 5988. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kook, A. M. Risitano, W. Zeng, M. Wlodarski, C. Lottemann, R. Nakamura, J. Barrett, N. S. Young, and J. P. Maciejewski Changes in T-cell receptor VB repertoire in aplastic anemia: effects of different immunosuppressive regimens Blood, May 15, 2002; 99(10): 3668 - 3675. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Fagerlie, J. Diaz, T. A. Christianson, K. McCartan, W. Keeble, G. R. Faulkner, and G. C. Bagby Functional correction of FA-C cells with FANCC suppresses the expression of interferon {gamma}-inducible genes Blood, May 15, 2001; 97(10): 3017 - 3024. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Choi, K. Muta, A. Wickrema, S. B. Krantz, J. Nishimura, and H. Nawata Interferon gamma delays apoptosis of mature erythroid progenitor cells in the absence of erythropoietin Blood, June 15, 2000; 95(12): 3742 - 3749. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Sloand, S. Kim, J. P. Maciejewski, F. Van Rhee, A. Chaudhuri, J. Barrett, and N. S. Young Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo Blood, April 1, 2000; 95(7): 2269 - 2274. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zeng, S. Nakao, H. Takamatsu, A. Yachie, A. Takami, Y. Kondo, N. Sugimori, H. Yamazaki, Y. Miura, S. Shiobara, et al. Characterization of T-Cell Repertoire of the Bone Marrow in Immune-Mediated Aplastic Anemia: Evidence for the Involvement of Antigen-Driven T-Cell Response in Cyclosporine-Dependent Aplastic Anemia Blood, May 1, 1999; 93(9): 3008 - 3016. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Murray, R. A. Young, and G. Q. Daley Hematopoietic Remodeling in Interferon-gamma -Deficient Mice Infected With Mycobacteria Blood, April 15, 1998; 91(8): 2914 - 2924. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sato, C. Selleri, N. S. Young, and J. P. Maciejewski Inhibition of Interferon Regulatory Factor-1 Expression Results in Predominance of Cell Growth Stimulatory Effects of Interferon-gamma Due to Phosphorylation of Stat1 and Stat3 Blood, December 15, 1997; 90(12): 4749 - 4758. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Jennings and K. A. Foon Recent Advances in Flow Cytometry: Application to the Diagnosis of Hematologic Malignancy Blood, October 15, 1997; 90(8): 2863 - 2892. [Full Text] [PDF] |
||||
![]() |
R. K. Rathbun, G. R. Faulkner, M. H. Ostroski, T. A. Christianson, G. Hughes, G. Jones, R. Cahn, R. Maziarz, G. Royle, W. Keeble, et al. Inactivation of the Fanconi Anemia Group C Gene Augments Interferon-gamma -Induced Apoptotic Responses in Hematopoietic Cells Blood, August 1, 1997; 90(3): 974 - 985. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Young and J. Maciejewski The Pathophysiology of Acquired Aplastic Anemia N. Engl. J. Med., May 8, 1997; 336(19): 1365 - 1372. [Full Text] [PDF] |
||||
![]() |
K. E. Brown, J. Tisdale, A. J. Barrett, C. E. Dunbar, and N. S. Young Hepatitis-Associated Aplastic Anemia N. Engl. J. Med., April 10, 1997; 336(15): 1059 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Young, D. M. Klinman, D. A. Reynolds, K. J. Grzegorzewski, A. Nii, J. M. Ward, R. T. Winkler-Pickett, J. R. Ortaldo, J. J. Kenny, and K. L. Komschlies Bone Marrow and Thymus Expression of Interferon-gamma Results in Severe B-Cell Lineage Reduction, T-Cell Lineage Alterations, and Hematopoietic Progenitor Deficiencies Blood, January 15, 1997; 89(2): 583 - 595. [Abstract] [Full Text] [PDF] |
||||